The global digital therapeutics (DTx) market is poised for rapid expansion, projected to grow from approximately USD 6.9 billion in 2025 to USD 27.8 billion by 2033, achieving a strong CAGR of 19.6% over this period. This growth is fueled by the rising prevalence of chronic diseases, the need for cost-effective, scalable, and personalized treatments, and technological advances such as...